Basic science mouse study of a common protein target shared in multiple cancers warrants further assessment in humans. No treatments on the horizon but this epitomizes good scientific research.

Dr. Barry Dworkin

Medical Mythbusting Commentary for January 23, 2020

Basic science mouse study of a common protein target shared in multiple cancers warrants further assessment in humans. No treatments on the horizon but this epitomizes good scientific research. Play Now | Play in Popup | Download

Source:
New scientific breakthrough could lead to ‘one-size-fits-all’ cancer treatment

Reference:
Genome-wide CRISPR–Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic MHC class I-related protein MR1

Related posts:

  1. Mouse model shows how ‘disgust’ receptors responsible for nicotine aversion leads to the next question of whether this is applicable in humans. If so, can these receptors be targeted to help someone quit? More basic science research is required.
  2. New online tool can help you understand and reduce your risk of common cancers
  3. Excellent basic science study looks at certain viruses as a contributing factor to the development of Alheimer’s
  4. Bad luck genes responsible for many cancers according to study but relies on statistical model that does not include breast and prostate cancer.
Bitnami